IRCT20200429047241N1尚未招募1 期
Personalized Immunology of Patients with Advanced Breast Cancer Using induced Pluripotent Stem Cell-Derived Natural Killer cells
International Center for Personalized Medicine (ICPM)0 个研究点目标入组 32 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 70 years（—）
- 性别
- Female
入选标准
- •Women with the diagnosis of ABC by any combination of ER, PR, and HER-2, who are progressed on chemotherapy and/or radiotherapy regimens for their metastatic disease.
- •Single metastasis patients with a measurable metastasis in the lymph node, lung, liver, and bone.
- •Women must be between 20 and 70 years of age.
排除标准
- •Patients with active and uncontrolled infections.
- •Abnormal kidney, lung and liver function, measured by serum creatinine (serum creatinine> 2 mg / dl), saturated oxygen O2 = 96%) (Sat and liver enzymes (ALT / AST> 2.5 x N).
- •Patients with the other types of cancers unrelated to the primary breast tumors
研究者
相似试验
进行中（未招募）
1 期
Complex immunomodulatory therapy for patients with immune thrombocytopenia (T-MEM)Immune thrombocytopeniaMedDRA version: 23.0Level: PTClassification code: 10083842Term: Immune thrombocytopenia Class: 100000004851CTIS2023-505788-35-00Fakultni Nemocnice Hradec Kralove73
招募中
1 期
Study of immunological activity after personalized immunomodulatory therapy regulating the Th17 pathway in patients with extramembranous glomerulonephritisExtramembranous glomerulonephritisCTIS2023-503226-39-00Centre Hospitalier Universitaire De Nice5
进行中（未招募）
1 期
Immunotherapy with differentiated T lymphocytes genetically modified in patients with classic Hodgkin's lymphoma and non-Hodgkin's lymphoma T with CD30 expressioClassic Hodgkin lymphoma and T-cell lymphoma with CD30 expressionEUCTR2019-001263-70-ESInstitut de Recerca H. de la Santa Creu i Sant Pau30
已完成
不适用
Improved diagnosis for patients with immune-mediated neuropathiesNL-OMON44505Academisch Medisch Centrum50
进行中（未招募）
不适用
Modulation of the immune response in patients with pancreatic tubular carcinoma - MIS-MITEUCTR2008-006710-23-SIBlood Transfusion Centre of Slovenia